Evidence map›Paper›PMID 33302549›Full record

ReviewBrain sciences2020

Role of Oligodendrocytes and Myelin in the Pathophysiology of Autism Spectrum Disorder.

Alma Y Galvez-Contreras, David Zarate-Lopez, Ana L Torres-Chavez, Oscar Gonzalez-Perez

Open access · goldAbstract readReview
In one paragraph

Review in Brain sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 121 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. The Neuroimmunology of Autism.Molecular neurobiology · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Alma Y Galvez-ContrerasDepartment of Neuroscience, Centro Universitario de Ciencias de la Salud, University of Guadalajara, Guadalajara 44340, Mexico.ORCID 0000-0001-7979-9086
David Zarate-LopezLaboratory of Neuroscience, School of Psychology, University of Colima, Colima 28040, Mexico.ORCID 0000-0001-8211-5757
Ana L Torres-ChavezLaboratory of Neuroscience, School of Psychology, University of Colima, Colima 28040, Mexico.
Oscar Gonzalez-PerezLaboratory of Neuroscience, School of Psychology, University of Colima, Colima 28040, Mexico.ORCID 0000-0002-6527-485X
Universidad de Colima · MXUniversidad de Guadalajara · MX

Funding

Consejo Nacional de Ciencia y Tecnología 2015-01-465Consejo Nacional de Ciencia y Tecnología 738774Consejo Nacional de Ciencia y Tecnología 857735
6 · The paper itself

Abstract

Autism Spectrum Disorder (ASD) is an early neurodevelopmental disorder that involves deficits in interpersonal communication, social interaction, and repetitive behaviors. Although ASD pathophysiology is still uncertain, alterations in the abnormal development of the frontal lobe, limbic areas, and putamen generate an imbalance between inhibition and excitation of neuronal activity. Interestingly, recent findings suggest that a disruption in neuronal connectivity is associated with neural alterations in white matter production and myelination in diverse brain regions of patients with ASD. This review is aimed to summarize the most recent evidence that supports the notion that abnormalities in the oligodendrocyte generation and axonal myelination in specific brain regions are involved in the pathophysiology of ASD. Fundamental molecular mediators of these pathological processes are also examined. Determining the role of alterations in oligodendrogenesis and myelination is a fundamental step to understand the pathophysiology of ASD and identify possible therapeutic targets.

Indexed as

epidermal growth factorinsulin-like growth factormyelinationoligodendrogenesis

Identifiers

PMID33302549
PMCPMC7764453
OpenAlexW3112892332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.